PYZTELUS

Serial Number 79367047
602

Registration Progress

Application Filed
Feb 28, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: PYZTELUS
Previous Owner: SAMSUNG BIOEPIS CO., LTD.
Classes: 005

Trademark Image

PYZTELUS

Basic Information

Serial Number
79367047
Filing Date
February 28, 2023
Abandonment Date
February 5, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Feb 15, 2024
Classes
005

Rights Holder

SAMSUNG BIOEPIS CO., LTD.

03
Address
76, Songdogyoyuk-ro, Yeonsu-gu
Incheon
KR

Ownership History

SAMSUNG BIOEPIS CO., LTD.

Original Applicant
03
KR

Application History

16 events
Date Code Type Description Documents
Mar 8, 2025 FINT P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Feb 17, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 16, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Feb 15, 2024 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Feb 15, 2024 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Feb 15, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Aug 22, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Aug 3, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 3, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 27, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 26, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 22, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 18, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 12, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 10, 2023 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Apr 7, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease; dietary supplements

Classification

International Classes
005